🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,756 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6676941

Antibody conjugate formulations for selectively inhibiting VEGF

The Board of Regents of the University of Texas System · Granted Tue Jan 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6673768

Transgenic animal models for cardiac hypertrophy and methods of use thereof (treating)

The Board of Regents of the University of Texas System · Granted Tue Jan 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6656471

HIV-specific T-cell induction

The Board of Regents of the University of Texas System · Granted Tue Dec 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6653351

Adjuvant chemotherapy for anaplastic gliomas

The Board of Regents of the University of Texas System · Granted Tue Nov 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6649631

Compositions and methods for treating bone deficit conditions

The Board of Regents of the University of Texas System · Granted Tue Nov 18 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6649593

Modulators of SREBP processing

The Board of Regents of the University of Texas System · Granted Tue Nov 18 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6632628

Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression

The Board of Regents of the University of Texas System · Granted Tue Oct 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6632626

Methods of assaying farnesyl transferase

The Board of Regents of the University of Texas System · Granted Tue Oct 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6632446

Coating substrates by polymerizing macromers having free radical-polymerizable substituent

The Board of Regents of the University of Texas System · Granted Tue Oct 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6630572

Thrombin derived polypeptides: compositions and methods for use

The Board of Regents of the University of Texas System · Granted Tue Oct 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6630170

Mesoporous compositions and method of preparation

The Board of Regents of the University of Texas System · Granted Tue Oct 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6627731

Thrombin derived polypeptides; compositions and methods for use

The Board of Regents of the University of Texas System · Granted Tue Sep 30 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6627189

Inhibition of cellular proliferation using ras antisense molecules

The Board of Regents of the University of Texas System · Granted Tue Sep 30 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6623957

Secretion of T cell receptor fragments from recombinant host cells

The Board of Regents of the University of Texas System · Granted Tue Sep 23 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6617441

Diagnostic test for borrelia infection

The Board of Regents of the University of Texas · Granted Tue Sep 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6613757

COMBINATION OF PROSTACYCLIN WITH AN ESTROGEN OR PROGESTIN FOR THE PREVENTION AND TREATMENT

The Board of Regents of the University of Texas System · Granted Tue Sep 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6608026

Apoptotic compounds

The Board of Regents of the University of Texas System · Granted Tue Aug 19 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6602975

Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-r

The Board of Regents of the University of Texas System · Granted Tue Aug 05 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6596296

Drug releasing biodegradable fiber implant

The Board of Regents of the University of Texas System · Granted Tue Jul 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6593306

Methods for modulation and inhibition of telomerase

The Board of Regents of the University of Texas System · Granted Tue Jul 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6586242

TAO protein kinases and methods of use therefor

The Board of Regents of the University of Texas System · Granted Tue Jul 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6582725

Human PEA3 is a tumor suppressor for cancer cells

The Board of Regents of the University of Texas System · Granted Tue Jun 24 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6579893

Use of troglitazone and related compounds for the treatment of cancer

The Board of Regents of the University of Texas System · Granted Tue Jun 17 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6576264

Insoluble drug delivery

The Board of Regents of the University of Texas System · Granted Tue Jun 10 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired